OliX Pharmaceuticals, Inc (KOSDAQ:226950)

OliX Pharmaceuticals Statistics

Total Valuation

KOSDAQ:226950 has a market cap or net worth of KRW 1.94 trillion. The enterprise value is 1.96 trillion.

Market Cap	1.94T
Enterprise Value	1.96T

Important Dates

The last earnings date was Thursday, August 14, 2025.

Earnings Date	Aug 14, 2025
Ex-Dividend Date	n/a

Share Statistics

KOSDAQ:226950 has 20.11 million shares outstanding. The number of shares has increased by 15.14% in one year.

Current Share Class	20.11M
Shares Outstanding	20.11M
Shares Change (YoY)	+15.14%
Shares Change (QoQ)	+5.67%
Owned by Insiders (%)	17.49%
Owned by Institutions (%)	15.17%
Float	16.60M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	257.02
PB Ratio	82.86
P/TBV Ratio	91.55
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-43.37
EV / Sales	259.74
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-61.98

Financial Position

The company has a current ratio of 0.95, with a Debt / Equity ratio of 1.18.

Current Ratio	0.95
Quick Ratio	0.88
Debt / Equity	1.18
Debt / EBITDA	n/a
Debt / FCF	-0.88
Interest Coverage	-7.77

Financial Efficiency

Return on equity (ROE) is -181.37% and return on invested capital (ROIC) is -30.22%.

Return on Equity (ROE)	-181.37%
Return on Assets (ROA)	-22.43%
Return on Invested Capital (ROIC)	-30.22%
Return on Capital Employed (ROCE)	-58.41%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.09
Inventory Turnover	0.44

Taxes

In the past 12 months, KOSDAQ:226950 has paid 2.42 billion in taxes.

Income Tax	2.42B
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +345.83% in the last 52 weeks. The beta is 0.85, so KOSDAQ:226950's price volatility has been lower than the market average.

Beta (5Y)	0.85
52-Week Price Change	+345.83%
50-Day Moving Average	70,949.00
200-Day Moving Average	46,462.60
Relative Strength Index (RSI)	62.09
Average Volume (20 Days)	1,229,012

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, KOSDAQ:226950 had revenue of KRW 7.54 billion and -45.14 billion in losses. Loss per share was -2,478.00.

Revenue	7.54B
Gross Profit	7.25B
Operating Income	-30.26B
Pretax Income	-42.72B
Net Income	-45.14B
EBITDA	-27.68B
EBIT	-30.26B
Loss Per Share	-2,478.00

Balance Sheet

The company has 7.81 billion in cash and 27.64 billion in debt, giving a net cash position of -19.83 billion or -986.01 per share.

Cash & Cash Equivalents	7.81B
Total Debt	27.64B
Net Cash	-19.83B
Net Cash Per Share	-986.01
Equity (Book Value)	23.38B
Book Value Per Share	1,147.17
Working Capital	-1.26B

Cash Flow

In the last 12 months, operating cash flow was -22.36 billion and capital expenditures -9.22 billion, giving a free cash flow of -31.58 billion.

Operating Cash Flow	-22.36B
Capital Expenditures	-9.22B
Free Cash Flow	-31.58B
FCF Per Share	-1,570.05

Margins

Gross Margin	96.20%
Operating Margin	-401.46%
Pretax Margin	-566.82%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

KOSDAQ:226950 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-15.14%
Shareholder Yield	n/a
Earnings Yield	-2.33%
FCF Yield	-1.63%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on December 3, 2020. It was a forward split with a ratio of 2.

Last Split Date	Dec 3, 2020
Split Type	Forward
Split Ratio	2

Scores

KOSDAQ:226950 has an Altman Z-Score of 1.25 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.25
Piotroski F-Score	3